Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes

被引:1
|
作者
Panes, J. [1 ]
Su, C. [2 ]
Bushmakin, A. G. [3 ]
Cappelleri, J. C. [3 ]
Mamolo, C. [3 ]
Healey, P. [3 ]
机构
[1] Hosp Clin Barcelona, Gastroenterol, Barcelona, Spain
[2] Pfizer Inc, Collegeville, PA USA
[3] Pfizer Inc, Groton, CT 06340 USA
来源
关键词
D O I
10.1016/S1873-9946(14)60100-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP075
引用
收藏
页码:S51 / S51
页数:1
相关论文
共 50 条
  • [21] Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
    Alessandro Armuzzi
    Ailsa Hart
    Joseph C. Cappelleri
    Nadir Mammar
    Peter Hur
    Benjamin Hoskin
    Fritha Hennessy
    Gary Milligan
    Axel Dignass
    [J]. BMC Gastroenterology, 23
  • [22] Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
    Armuzzi, Alessandro
    Hart, Ailsa
    Cappelleri, Joseph C. C.
    Mammar, Nadir
    Hur, Peter
    Hoskin, Benjamin
    Hennessy, Fritha
    Milligan, Gary
    Dignass, Axel
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [23] Comparative efficacy and impact on patient-reported outcomes of pharmacological therapies for moderate to severe ulcerative colitis: a systematic review and network meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S290 - S291
  • [24] Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
    Shehab, Mohammad
    Hassan, Amro
    Alrashed, Fatema
    Abbas, Adnan
    Ma, Christopher
    Narula, Neeraj
    Jairath, Vipul
    Singh, Siddharth
    Bessissow, Talat
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [25] Patient-reported adherence rates to topical therapies in ulcerative colitis
    Hendy, P.
    Shuvo, M.
    Hart, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S419 - S419
  • [26] Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis
    Ma, Christopher
    Sandborn, William J.
    D'Haens, Geert R.
    Zou, Guangyong
    Stitt, Larry W.
    Singh, Siddharth
    Ananthakrishnan, Ashwin N.
    Dulai, Parambir S.
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) : 1760 - +
  • [27] CAN WE SIMPLIFY THE PEDIATRIC ULCERATIVE COLITIS INDEX TO THE POINT OF PATIENT-REPORTED OUTCOMES ONLY?
    Grossi, Victoria
    Wang, Zhu
    Griffiths, Anne M.
    Mack, David R.
    Boyle, Brendan M.
    Leleiko, Neal S.
    Sauer, Cary G.
    Rosh, Joel R.
    Keljo, David J.
    Markowitz, James
    Baker, Susan S.
    Baldassano, Robert N.
    Patel, Ashish S.
    Pfefferkorn, Marian D.
    Otley, Anthony
    Heyman, Mel
    Noe, Joshua D.
    Oliva-Hemker, Maria
    Rufo, Paul A.
    Kugathasan, Subra
    Walters, Thomas D.
    Church, Peter
    Denson, Lee A.
    Hyams, Jeffrey S.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S952 - S952
  • [28] Usefulness of Examining Various Patient-Reported Outcomes in Predicting Endoscopic Mucosal Healing in Ulcerative Colitis
    Moon, Jung Min
    Yoon, Hyuk
    Park, Jihye
    Shin, Cheol Min
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    Kim, Joo Sung
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (08): : 682 - +
  • [29] Ulcerative colitis: efficacy and safety of tofacitinib studied
    Kessing, Richard
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (10):
  • [30] Analysis and interpretation of results based on patient-reported outcomes
    Sloan, Jeff A.
    Dueck, Amylou C.
    Erickson, Pennifer A.
    Guess, Harry
    Revicki, Dennis A.
    Santanello, Nancy C.
    Sloan, Jeff A.
    [J]. VALUE IN HEALTH, 2007, 10 : S106 - S115